Cold weather and joint pain: What is the connection?
Effects
Who it affects
Managing pain
Contacting a doctor
FAQ
Summary
Cold weather may worsen joint pain in some people, such as those with arthritis or orthopedic implants. Keeping warm by dressing appropriately for the weather and using draft excluders at home may help.
Many people with health conditions such as arthritis report worsening joint pain when temperatures drop. Some research supports this, but more studies may be necessary for scientists to understand exactly why this happens and how common it is.
Taking steps to stay warm may help reduce joint pain during cold weather. However, if someone experiences severe or persistent pain that interferes with their daily life, it is a good idea to speak with a healthcare professional. CatherineHistorically, most evidence of a link between cold weather and joint pain was anecdotal. However, in recent years, more researchers are investigating a cause-and-effect link.
A 2025 review suggests that low temperatures may affect: compliance of the periarticular structures, which are tissues around a joint
viscosity (resistance to flow) of synovial fluid, which is in joint cavities
the ability of substances to pass through blood vessels, which may affect inflammation
blood vessel constriction
These effects may lead to increased joint pain and stiffness during cold weather.
A 2023 systematic review of 14 studies suggests a correlation between increased osteoarthritis joint pain and lower temperatures, as well as increased atmospheric pressure and relative humidity.
A potential cause for this is an overexpression of thermosensitive transient receptor potential channels (thermo-TRPs) in cold weather. Thermo-TRPs are a type of protein structure in cells involved in functions such as body temperature regulation and pain perception.
However, the researchers conclude that more research is necessary to fully understand the links between osteoarthritis pain and weather conditions, including temperature.
According to the 2025 review, cold weather may affect how people use care resources for health conditions such as arthritis.
For example, lower temperatures may make people less likely to use physical therapy, which could contribute to increases in their symptoms.
The Arthritis Foundation also suggests that cold weather may contribute to lower moods, which may cause people to focus more on their pain.
More research is necessary to understand exactly how cold weather affects joint pain and other factors that may contribute.
Not everyone will experience joint pain when it gets colder. However, certain health conditions may increase a person's chance.
Pain is subjective and varies from person to person, even among people with the same health conditions. Mild pain for one person may feel severe for another. So, there is no guarantee everyone with arthritis will have painful joints when it gets colder.
A 2020 study also suggests a link between cold weather and increased pain in people with orthopedic implants, such as joint replacements.
If someone tends to experience worsening joint pain in colder temperatures, it can help to monitor weather forecasts to anticipate weather changes before they happen and take steps to prepare.
Keeping warm may help reduce joint pain due to cold weather. People can try the following steps: wear warm clothes, such as gloves and multiple layers
choose clothes made from insulating materials, such as wool
use hot water bottles or portable hand warmers
use heat pads or heated blankets at home
place draft excluders or door sweeps on doors at home
eat a hot meal or drink a warm drink
move around to boost circulation
If someone has a health condition that affects their joints, sticking to their treatment plan even during cold weather can help prevent worsening joint pain.
A person's symptoms may differ depending on factors such as underlying health conditions, current treatments, and more.
If someone does not have a diagnosed health condition but starts experiencing persistent or frequent joint pain, a doctor can diagnose the underlying cause.
People with a health condition, such as arthritis, may benefit from speaking with a healthcare professional if they experience a severe flare-up or worsening symptoms.
Their healthcare team may wish to change their current treatment plan to help them manage their symptoms.
Although warmer temperatures may improve joint pain for some people, other weather factors, such as humidity and barometric pressure, can also affect joint pain. Treatment compliance and other factors may also contribute.
The Arthritis Foundation suggests there is no guarantee a warmer climate will help. However, people can visit a new climate at different times throughout the year before committing to moving to see if their symptoms improve.
No scientific studies support an 'ideal' temperature to reduce joint pain. The most comfortable temperature to relieve joint pain may vary from person to person.
People can use a symptom journal to help work out what temperatures seem to relieve their joint pain and what temperatures worsen it.
No scientific research supports using copper or magnetic bracelets to relieve joint pain during cold weather. However, the Arthritis Foundation suggests there is no harm in trying this remedy alongside a doctor-approved treatment plan.
Some people may find that their symptoms improve due to the placebo effect.
Cold weather may trigger or worsen joint pain in certain people, such as those with arthritis or joint replacements.
Low temperatures may affect the fluid and tissues in and around joints, causing pain and stiffness. People may also focus on symptoms more and be less likely to follow treatment plans in cold weather.
Taking steps to keep warm may help relieve joint pain that worsens in cold weather. This may include wearing multiple layers, using hand warmers or heat pads, and fitting draft excluders at home. Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources to ensure content accuracy and integrity. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
44 minutes ago
- The Independent
US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need
US medicines regulator the Food and Drug Administration (FDA) has approved a groundbreaking HIV prevention jab hailed as having the potential to quell the Aids pandemic. But the moment has been overshadowed by the spectre of aid cuts, placing in doubt whether this breakthrough injection – lenacapavir – will get to the people who need it most. Lenacapavir given in a twice-yearly injection stops HIV from replicating, protecting close to 100 per cent of people from developing the virus if they are exposed to it. This approval is one of the last crucial steps to getting the drug, branded Yeztugo, out to patients. Although the FDA's approval only applies to US patients, the World Health Organization (WHO) said it paved the way for its own recommendation of the drug and for approval in other countries. Director of WHO's Global HIV, Hepatitis and STI Programmes, Dr Meg Doherty described it as a 'regulatory milestone' adding: 'We are working with partners and national authorities to ensure lenacapavir reaches people who need it most – quickly, safely and equitably.' Researchers have raised concerns that, amid aid cuts, the jab will be too expensive to be taken up by lower-income countries. Gilead – the drugs company producing lencapavir – did not make public the cost of each dose to global funders but it announced a US price of $28,218 per year for each patient. 'If this game-changing medicine remains unaffordable, it will change nothing,' said Winnie Byanyima, executive director of the United Nations' Aids agency, UNAIDS. She called the approval of lenacapavir a 'breakthrough moment' adding the jab, 'could be the tool we need to bring new infections under control – but only if it is priced affordably and made available to everyone who could benefit. ' UNAIDS has seen research that lenacapavir can be produced for just $40 per person per year, falling to $25 within a year of roll out. It is beyond comprehension how Gilead can justify a price of $28,218.' Dr Andrew Hill, a pharmacology research fellow at the University of Liverpool, worked on the research which found lenacapavir could be provided for as little as $25, including a 30 per cent profit margin. 'Scientifically, it's a great moment that we have a drug which has been judged to be safe and efficacious by a leading regulatory authority in the world,'' he said. 'Public health-wise and in terms of the epidemic, it's tragic because the drug is so expensive that it's not going to get used'. It is also unlikely to be affordable in the UK, he said, despite government promises to end new cases of HIV in England by 2030. A Gilead spokesperson said, 'Yeztugo is priced in line with existing branded PrEP [pre-exposure prophylaxis] options. We are working to make Yeztugo accessible for anyone who needs or wants it and expect to see broad insurance coverage in the US. 'We're taking unprecedented actions with urgency to plan for access to lenacapavir for PrEP globally—particularly in low- and lower-middle-income countries where the need is greatest.' Gilead signed agreements with six pharmaceutical companies in India, Pakistan, Egypt, and the US to allow them to make generic versions of the drug in order to increase supply and drive down the cost of the jab. This will take some time. Gilead also agreed to sell enough doses of the jab to protect at least two million people over three years in lower-income countries. These would be paid for by global funders led by the US President's Emergency Plan for Aids Relief (Pepfar) and the Global Fund to Fight Aids, Tuberculosis and Malaria. However, The Independent reported earlier in the month that these doses are now at risk because of US funding cuts. A significant chunk of the money to fund the doses of lenacapavir was set to come from the US-led global Aids response programme, Pepfar, as well as the Global Fund whose biggest donor was the US. This funding is now uncertain. Figures previously reported by The Independent suggest President Trump's slashing of foreign aid has derailed the projected end of the Aids pandemic and could lead to four million extra deaths by 2030. 'It does feel like this thing that could help us end the epidemic sooner is suddenly receding in the chaos,' said Prof Linda-Gail Bekker, whose trial demonstrated lenacapavir's effectiveness. The aid-funded doses are thought to cost much less than the US list price of almost $30k but still roughly five times more expensive than Dr Hill believes is necessary. And they are in an initial pilot phase, he said: 'We need to get into a different level where we're giving lenacapavir to tens of millions of people'. This is even more important as aid cuts are slashing the HIV prevention budgets of governments across Africa, he said. 'We're in this crazy position where we have a brand new highly effective vaccine-like drug and actually we will probably see the epidemic get worse over the next four years.'
The Independent
an hour ago
- The Independent
Health officials issue warnings as UK bakes in the first heat wave of 2025
British health officials are warning people across the country to take precautions when out in the sun as the U.K. bakes under its first heat wave of the year. Temperatures are expected to peak at 34 degrees Celsius (93 degrees Fahrenheit) in some parts of eastern England on Saturday following a week of unusually warm weather, according to the national weather agency the Met Office. That's about 12 C (22 F) higher than normal for this time of year. The U.K. Health Security Agency has issued an amber heat health alert covering all of England because of increased health risks for people over 65 and those with heart and lung problems. ' Heat can result in serious health outcomes across the population, especially for older adults or those with pre-existing health conditions,' Dr. Agostinho Sousa, head of the UKHSA, said in a statement. 'It is therefore important to check on friends, family and neighbors who are more vulnerable and to take sensible precautions while enjoying the sun.' Saturday is expected to be the hottest day of the heat wave, with temperatures falling slightly on Sunday and dropping back into the more normal temperatures next week, the Met Office said. The heat alert is currently scheduled to remain in effect until Monday morning. Unusually, temperatures in London this week have been higher than in many parts of Western Europe. That's because the high temperatures are not the result of hot air moving north from the Iberian Peninsula or North Africa as is often the case, the Met Office said. Instead, this weather system originated in air high over the Atlantic Ocean south of Greenland. As it approaches the U.K., it descends toward ground level, causing it to warm rapidly, Chief Meteorologist Matthew Lenhert said. That said, it has been plenty hot in Europe too. Aviation enthusiasts attending the Paris Air Show in Le Bourget, north of Paris, this week sought the shade of a Boeing 777's wing, cooling off as temperatures hovered in the low 30s C (mid-80s F.) Met Office scientists this week published research showing that climate change is increasing the likelihood of extreme high temperatures in the U.K. The chance of temperatures exceeding 40 Celsius (104 F) is now more than 20 times higher than it was in the 1960s, the researchers said.
Daily Mail
an hour ago
- Daily Mail
Panic mounts as social security's cash shortfall date revealed
The US Social Security and Medicare programs for seniors will both run short of funds to pay full benefits in 2033. The go-broke dates the two trust funds have moved up due to rising health care costs and new legislation affecting Social Security benefits, according to an annual report released Wednesday. The yearly assessment found that Medicare's hospital insurance trust fund will be unable to fully cover costs beginning in 2033 — three years earlier than last year's estimate. Higher-than-forecast hospitalizations of Americans over 65 years old was a key factor. Social Security's combined trust funds, which support retirement and disability benefits to 70 million Americans, are also expected to be depleted in 2033. While the year was unchanged from last year's report, it was advanced by three calendar quarters within that year. The projections reflect higher-than-expected healthcare spending, along with recent legislation that increased Social Security benefits for some workers. Once the funds are exhausted, beneficiaries would still receive payments, but at reduced levels. Medicare would be able to cover just 89 percent of hospital costs, while Social Security could pay only about 81 percent of promised benefits. The trustees say the latest findings show the urgency of needed changes to the programs, which have faced dire financial projections for decades. But making changes to the programs has long been politically unpopular, and lawmakers have repeatedly kicked Social Security and Medicare´s troubling math to the next generation. President Donald Trump and other Republicans have vowed not to make any cuts to Medicare or Social Security, even as they seek to shrink the federal government´s expenditures. 'The financial status of the trust funds remains a top priority for the administration,' said Social Security Administration commissioner Frank Bisignano (pictured) in a statement. The new forecast adds urgency to a long-standing challenge facing Congress, which has repeatedly delayed making reforms due to political sensitivity around the issue. Lawmakers would need to act — either by raising taxes, reducing benefits, or both —to ensure long-term solvency. President Donald Trump and many Republican lawmakers have pledged not to cut Medicare or Social Security benefits, but critics say recent legislative changes have worsened the programs' financial outlook. One provision enacted in January—the Social Security Fairness Act—eliminated two rules that had reduced benefits for certain workers, effectively increasing payments and accelerating the trust fund's projected depletion. Romina Boccia (pictured), director of budget and entitlement policy at the CATO Institute, called the change 'a political giveaway masquerading as reform.' Instead of tackling Social Security´s structural imbalances, Congress chose to increase benefits for a vocal minority-accelerating trust fund insolvency.' About 68 million Americans are currently enrolled in Medicare, and more than 70 million receive Social Security benefits. Both programs are primarily funded through payroll taxes, but costs are projected to outpace revenues due to the country's aging population and rising healthcare expenses. Experts say failure to act soon could result in sudden benefit cuts and instability for millions of retirees and disabled Americans. 'Congress must act to protect and strengthen the Social Security that Americans have earned and paid into,' said AARP CEO Myechia Minter-Jordan (pictured). Several policy proposals have been floated in recent years, but none have gained significant momentum. The last major reform to Social Security came in 1983, when the eligibility age for full retirement benefits was raised from 65 to 67. Without further legislative changes, the federal programs that serve as the backbone of retirement security in the US could face significant challenges within the next decade. Last year, billionaire CEO Larry Fink (pictured) said Americans should work beyond the age of 65 to stop the Social Security system collapsing. Meanwhile, experts recently said Americans are making a big mistake by claiming their Social Security checks early, since delaying their claims could lead to higher payments. Every year you delay taking a Social Security payment after full retirement age you receive a significant increase in payments up to the age of 70.
